These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 20013845

  • 1. In reference to Squamous cell carcinoma associated with intralesional injection of cidofovir for recurrent respiratory papillomatosis.
    Preuss SF, Quante G.
    Laryngoscope; 2010 Mar; 120(3):650; author reply 651. PubMed ID: 20013845
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Treatment of recurrent respiratory papillomatosis and adverse reactions following off-label use of cidofovir (Vistide®).
    Tjon Pian Gi RE, Dietz A, Djukic V, Eckel HE, Friedrich G, Golusinski W, Hantzakos A, Lawson G, Remacle M, Rihkanen H, Dikkers FG.
    Eur Arch Otorhinolaryngol; 2012 Feb; 269(2):361-2. PubMed ID: 22020697
    [No Abstract] [Full Text] [Related]

  • 6. Delivery of cidofovir to respiratory papillomas of the distal trachea.
    Cullen RD, Zdanski C.
    Laryngoscope; 2005 Mar; 115(3):552-4. PubMed ID: 15744176
    [No Abstract] [Full Text] [Related]

  • 7. Serial office-based intralesional injection of cidofovir in adult-onset recurrent respiratory papillomatosis.
    Co J, Woo P.
    Ann Otol Rhinol Laryngol; 2004 Nov; 113(11):859-62. PubMed ID: 15562893
    [Abstract] [Full Text] [Related]

  • 8. Adult intralesional cidofovir therapy for laryngeal papilloma: a 10-year perspective.
    Tanna N, Sidell D, Joshi AS, Bielamowicz SA.
    Arch Otolaryngol Head Neck Surg; 2008 May; 134(5):497-500. PubMed ID: 18490570
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Urrets-Zavalia syndrome as a complication of ocular hypotonia due to intravenous cidofovir treatment.
    Orssaud C, Wermert D, Roux A, Laccourreye O, Sors H, Roche O, Dufier JL.
    Eye (Lond); 2014 Jun; 28(6):776-7. PubMed ID: 24675584
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Office-based intralesional cidofovir injections for nasal septal papilloma: a pilot study.
    Shemen LJ, Shnayder Y.
    Otolaryngol Head Neck Surg; 2006 Jul; 135(1):149-51. PubMed ID: 16815201
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Is intralesional cidofovir worthwhile in juvenile recurrent respiratory papillomatosis?
    Sheahan P, Sexton S, Russell JD.
    J Laryngol Otol; 2006 Jul; 120(7):561-5. PubMed ID: 16834805
    [Abstract] [Full Text] [Related]

  • 18. [The schedule of intralesional papillomatosis treatment with cidofovir].
    Szyfter W, Wierzbicka M, Jackowska J, Bartochowska A, Banaszewski J.
    Otolaryngol Pol; 2010 Jul; 64(2):98-102. PubMed ID: 20568538
    [Abstract] [Full Text] [Related]

  • 19. 3.5-Year follow-up of intralesional cidofovir protocol for pediatric recurrent respiratory papillomatosis.
    Chung BJ, Akst LM, Koltai PJ.
    Int J Pediatr Otorhinolaryngol; 2006 Nov; 70(11):1911-7. PubMed ID: 16919339
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.